Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IMNR - Immune Response -- Ignore unavailable to you. Want to Upgrade?

To: Robert DeHaven who wrote (424)	6/3/1998 12:34:00 PM
From: Don Hurst	Read Replies (1) \| Respond to of 1510

Today's WSJ has a big article on the front page of the B section headlined "FDA allows Large-Scale Trial of AIDS Vaccine" by a company named VaxGen Inc. It says that Phase III trial will include 5000 volunteers in USA and 2500 in Thailand. "This is a watershed event in the AIDS crisis" says Seth Barkley, president of the nonprofit International AIDS Vaccine Initiative. Article tone is that this is really a big deal but not one word in the article about IMNR or Remune. Any opinions out there? Regards, Don